MindMaze Therapeutics Holding SA (SWX:MMTX)
Switzerland · Delayed Price · Currency is CHF 0.3010
-0.0360 (-10.68%)
Apr 24, 2026, 5:30 PM CET
MindMaze Therapeutics Holding Company Description
MindMaze Therapeutics Holding SA develops and operates the MindMaze platform that integrates neuroscience and digital therapeutics to address some of the most pressing challenges in neurology.
The company was founded in 2025 and is based in Lausanne, Switzerland.
MindMaze Therapeutics Holding SA
| Country | Switzerland |
| Founded | 2025 |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Zach Henderson |
Contact Details
Address: Chemin de Roseneck 5 Lausanne, 1006 Switzerland | |
| Phone | 41 21 552 08 01 |
| Website | mindmazetherapeutics.com |
Stock Details
| Ticker Symbol | MMTX |
| Exchange | SIX Swiss Exchange |
| Reporting Currency | CHF |
| ISIN Number | CH1251125998 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Zach W. Henderson | Chief Executive Officer |
| Jeremy Meinen CPA | Chief Financial Officer |
| Alexandre Capet | Chief Operating and Strategy Officer |
| Frédéric Condolo | Chief Technology Officer |
| Paolo Galfetti | Chief Business Officer |